{"organizations": [], "uuid": "9671aaefcc9386c3337addc72031dac9d1edaf40", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180130.html", "section_title": "Archive News &amp; Video for Tuesday, 30 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-bracco-diagnostics-receives-fda-ap/brief-bracco-diagnostics-receives-fda-approval-for-use-of-multihance-injection-in-patients-younger-than-2-idUSASB0C2Z6", "country": "US", "domain_rank": 408, "title": "BRIEF-Bracco Diagnostics Receives FDA Approval For Use Of Multihance Injection In Patients Younger Than 2", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.994, "site_type": "news", "published": "2018-01-30T21:15:00.000+02:00", "replies_count": 0, "uuid": "9671aaefcc9386c3337addc72031dac9d1edaf40"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-bracco-diagnostics-receives-fda-ap/brief-bracco-diagnostics-receives-fda-approval-for-use-of-multihance-injection-in-patients-younger-than-2-idUSASB0C2Z6", "ord_in_thread": 0, "title": "BRIEF-Bracco Diagnostics Receives FDA Approval For Use Of Multihance Injection In Patients Younger Than 2", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-bracco diagnostics", "sentiment": "negative"}, {"name": "bracco diagnostics inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 30 (Reuters) - Bracco Diagnostics Inc:\n* BRACCO DIAGNOSTICS INC. RECEIVES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL FOR USE OF MULTIHANCEÂ® (GADOBENATE DIMEGLUMINE) INJECTION, 529 MG/ML IN MAGNETIC RESONANCE IMAGING (MRI) OF THE CENTRAL NERVOUS SYSTEM (CNS) IN PEDIATRIC PATIENTS YOUNGER TH Source text for Eikon:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-30T21:15:00.000+02:00", "crawled": "2018-01-31T16:51:57.010+02:00", "highlightTitle": ""}